Why is Clinitech Lab falling/rising?

As of 08-Sep, Clinitech Laboratory Ltd is experiencing a price increase, currently at Rs 54.50, reflecting a rise of 2.13 (4.07%). The stock has been on an upward trend, gaining for the last three days with a total return of 11.66% during this period. It has outperformed its sector by 4.39% today. However, despite this positive movement, there has been a notable decline in investor participation, with delivery volume dropping by 76.19% against the 5-day average. The stock's performance over the past week shows a gain of 3.34%, and over the past month, it has increased by 25.84%, although it remains down 30.89% year-to-date and 33.54% over the past year.
In the broader market context, the Sensex has shown a modest gain of 0.53% over the past week and 1.16% over the past month, indicating that Clinitech's recent performance is significantly stronger than the benchmark. This suggests that the stock's rise is driven by factors specific to the company rather than overall market trends. Despite the stock's current upward trajectory, its year-to-date and one-year performance remains negative compared to the Sensex, which has gained 3.39% and is down only 0.49% respectively over the same periods.